Dearnaley, D P <br/><br/>
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.  [electronic resource] 

 -  British journal of cancer  Feb 2005 
 - 488-98 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6602301  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--radiotherapy<br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Cyproterone--therapeutic use<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Pilot Projects<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--radiotherapy<br/>Radiation Injuries<br/>Radiotherapy Dosage<br/>Radiotherapy, Conformal--adverse effects<br/>Rectum--radiation effects<br/>Treatment Outcome<br/>Urinary Bladder--radiation effects